As of 3:59pm ET
| +1.42 / +1.12%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 137.00, with a high estimate of 160.00 and a low estimate of 104.00. The median estimate represents a +7.06% increase from the last price of 127.97.
The current consensus among 5 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.